MEDIMMUNE LIMITED (02451177) is a private limited company registered in CAMBRIDGE, incorporated in 1989. The company operates in the other research and experimental development on natural sciences and engineering sector. Our database holds 89 signals from 10 official sources covering this company's filings, appointments, and regulatory records. Risk assessment: 90/100 ("robust"), reflecting a strong compliance and financial profile. The company has 5 outstanding mortgage charges registered with Companies House.
Medimmune Limited is an active private company incorporated in 1989, focusing on research and development in natural sciences and engineering, located in Cambridge.
Good data coverage from 10 sources. Risk score of 90 indicates a strong compliance profile.
MEDIMMUNE LIMITED is 1 of 243 other research and experimental development on natural sciences and engineering companies in CAMBRIDGE, out of 5,626 active companies in this sector nationally (6,152 including dissolved).
The 11 directors of MEDIMMUNE LIMITED are connected to 30 other companies.
None of these connected companies have been dissolved.
MEDIMMUNE LIMITED is listed as the proprietor of 9 properties in the HM Land Registry.
Properties are located in East Anglia, Greater London.
MEDIMMUNE LIMITED has received 6 Innovate UK grants. This demonstrates a strong commitment to research and innovation.
MEDIMMUNE LIMITED pays invoices in an average of 54 days. 2% are paid within 30 days.
This company profile is built from 9 official data sources: Ch Officers, Companies House, Gateway to Research, Gender Pay Gap Service, HM Land Registry, ICO, Innovate UK, Modern Slavery Registry, Payment Practices.
Medimmune Limited is an active private company incorporated in 1989, focusing on research and development in natural sciences and engineering, located in Cambridge..
Current directors include , , and 2 more.
MEDIMMUNE LIMITED is registered in CAMBRIDGE, United Kingdom.
MEDIMMUNE LIMITED operates under SIC code 72190 — Other research and experimental development on natural sciences and engineering.
MEDIMMUNE LIMITED has a risk score of 90 out of 100, classified as "Robust". This score is calculated from 89 data signals across 10 government sources.
The next accounts for MEDIMMUNE LIMITED are due on 30 Sept 2026.
Yes, MEDIMMUNE LIMITED was previously known as CAMBRIDGE ANTIBODY TECHNOLOGY LIMITED.
Yes, MEDIMMUNE LIMITED is listed as the proprietor of 9 properties in the HM Land Registry, located in East Anglia, Greater London.
The dissolution rate for the other research and experimental development on natural sciences and engineering sector in the UK is 0.2%. The average company age in this sector is 10.7 years.
MEDIMMUNE LIMITED is currently listed as "Active" on Companies House, indicating it is still a registered company. An "Active" status means the company has not been dissolved, struck off, or entered into liquidation.
MEDIMMUNE LIMITED is registered as a Private Limited Company, which is a company limited by shares whose shares are not offered to the general public. It is the most common type of UK company, offering limited liability to its shareholders.
MEDIMMUNE LIMITED was incorporated on 11 Dec 1989, making it 37 years old. The company remains active and in good standing.
MEDIMMUNE LIMITED is classified under SIC code 72190 (Other research and experimental development on natural sciences and engineering). The Standard Industrial Classification system is used by the UK government to categorise businesses by their primary economic activity.
We track 89 data signals from 10 official government sources for MEDIMMUNE LIMITED.